The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...
A report from Zhongshan Daily & Zhongshan International Communications Center: In July 2024, the elderly health care vouchers of Hong Kong could be used in Zhongshan Chenxinghai Hospital. Zhongshan ...
National Human Rights Commission wrote to YouTube seeking removal of the videos featuring Ranveer Allahbadia. Interestingly, ...
Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...
A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.
Latent Labs’ platform does just that: by empowering researchers to computationally create new therapeutic molecules, such as antibodies or enzymes, the AI lab will help partners unlock previously ...
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
Your brain constantly juggles sensory information to make split-second decisions, but how? A new latent circuit model ...
Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback